These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3488322)

  • 21. Regional kinetic constants and cerebral metabolic rate for glucose in normal human volunteers determined by dynamic positron emission tomography of [18F]-2-fluoro-2-deoxy-D-glucose.
    Heiss WD; Pawlik G; Herholz K; Wagner R; Göldner H; Wienhard K
    J Cereb Blood Flow Metab; 1984 Jun; 4(2):212-23. PubMed ID: 6609929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cerebral glucography with positron tomography. Use in normal subjects and in patients with schizophrenia.
    Buchsbaum MS; Ingvar DH; Kessler R; Waters RN; Cappelletti J; van Kammen DP; King AC; Johnson JL; Manning RG; Flynn RW; Mann LS; Bunney WE; Sokoloff L
    Arch Gen Psychiatry; 1982 Mar; 39(3):251-9. PubMed ID: 6978119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reproducibility of cerebral glucose metabolic measurements in resting human subjects.
    Bartlett EJ; Brodie JD; Wolf AP; Christman DR; Laska E; Meissner M
    J Cereb Blood Flow Metab; 1988 Aug; 8(4):502-12. PubMed ID: 3260593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decreased brain metabolism in neurologically intact healthy alcoholics.
    Volkow ND; Hitzemann R; Wang GJ; Fowler JS; Burr G; Pascani K; Dewey SL; Wolf AP
    Am J Psychiatry; 1992 Aug; 149(8):1016-22. PubMed ID: 1636801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative regional analysis of 2-fluorodeoxyglucose and methylglucose uptake in brain of four stroke patients. With special reference to the regional estimation of the lumped constant.
    Gjedde A; Wienhard K; Heiss WD; Kloster G; Diemer NH; Herholz K; Pawlik G
    J Cereb Blood Flow Metab; 1985 Jun; 5(2):163-78. PubMed ID: 3872872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positron emission tomographic image measurement in schizophrenia and affective disorders.
    Buchsbaum MS; Cappelletti J; Ball R; Hazlett E; King AC; Johnson J; Wu J; DeLisi LE
    Ann Neurol; 1984; 15 Suppl():S157-65. PubMed ID: 6611116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormal glucose metabolism in the mediodorsal nucleus of the thalamus in schizophrenia.
    Hazlett EA; Buchsbaum MS; Kemether E; Bloom R; Platholi J; Brickman AM; Shihabuddin L; Tang C; Byne W
    Am J Psychiatry; 2004 Feb; 161(2):305-14. PubMed ID: 14754780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intersubject variability of brain glucose metabolic measurements in young normal males.
    Wang GJ; Volkow ND; Wolf AP; Brodie JD; Hitzemann RJ
    J Nucl Med; 1994 Sep; 35(9):1457-66. PubMed ID: 8071692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression.
    Kling AS; Metter EJ; Riege WH; Kuhl DE
    Am J Psychiatry; 1986 Feb; 143(2):175-80. PubMed ID: 3946650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlational methods for determining regional coupling of cerebral glucose metabolism: a pilot study.
    Clark CM; Kessler R; Buchsbaum MS; Margolin RA; Holcomb HH
    Biol Psychiatry; 1984 May; 19(5):663-78. PubMed ID: 6610442
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histamine H1 receptors in schizophrenic patients measured by positron emission tomography.
    Iwabuchi K; Ito C; Tashiro M; Kato M; Kano M; Itoh M; Iwata R; Matsuoka H; Sato M; Yanai K
    Eur Neuropsychopharmacol; 2005 Mar; 15(2):185-91. PubMed ID: 15695063
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebral hypometabolism in progressive supranuclear palsy studied with positron emission tomography.
    Foster NL; Gilman S; Berent S; Morin EM; Brown MB; Koeppe RA
    Ann Neurol; 1988 Sep; 24(3):399-406. PubMed ID: 3265862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Age differences in intercorrelations between regional cerebral metabolic rates for glucose.
    Horwitz B; Duara R; Rapoport SI
    Ann Neurol; 1986 Jan; 19(1):60-7. PubMed ID: 3484930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of sleep deprivation on cerebral glucose metabolic rate in normal humans assessed with positron emission tomography.
    Wu JC; Gillin JC; Buchsbaum MS; Hershey T; Hazlett E; Sicotte N; Bunney WE
    Sleep; 1991 Apr; 14(2):155-62. PubMed ID: 1866529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of amphetamine on local cerebral metabolism in normal and schizophrenic subjects as determined by positron emission tomography.
    Wolkin A; Angrist B; Wolf A; Brodie J; Wolkin B; Jaeger J; Cancro R; Rotrosen J
    Psychopharmacology (Berl); 1987; 92(2):241-6. PubMed ID: 3110848
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Cerebral glucose metabolism in autistic children. Study and positron emission tomography].
    De Volder AG; Bol A; Michel C; Cogneau M; Goffinet AM
    Acta Neurol Belg; 1988; 88(2):75-90. PubMed ID: 3260437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral glucose metabolism in patients with summer seasonal affective disorder.
    Goyer PF; Schulz PM; Semple WE; Gross M; Nordahl TE; King AC; Wehr TA; Cohen RM
    Neuropsychopharmacology; 1992 Nov; 7(3):233-40. PubMed ID: 1388646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Brain imaging in the search for biological markers in affective disorder.
    Buchsbaum MS
    J Clin Psychiatry; 1986 Oct; 47 Suppl():7-12. PubMed ID: 3489711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Low cerebellar metabolism in medicated patients with chronic schizophrenia.
    Volkow ND; Levy A; Brodie JD; Wolf AP; Cancro R; Van Gelder P; Henn F
    Am J Psychiatry; 1992 May; 149(5):686-8. PubMed ID: 1575261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral glucose metabolic differences in patients with panic disorder.
    Nordahl TE; Semple WE; Gross M; Mellman TA; Stein MB; Goyer P; King AC; Uhde TW; Cohen RM
    Neuropsychopharmacology; 1990 Aug; 3(4):261-72. PubMed ID: 2400544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.